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Chronic Air Pollution Exposure
and Endothelial Dysfunction
What You Can’t See—
Can Harm You*
Robert D. Brook, MD,† Sanjay Rajagopalan, MD‡
Ann Arbor, Michigan; and Columbus, Ohio
Fine particulate matter air pollution 2.5 m in diameter
(PM2.5), a pervasive and often “invisible” component of
odern-day atmospheres, has been linked to numerous
dverse outcomes, including increased cardiovascular (CV)
orbidity and mortality. Indeed, an American Heart Asso-
iation scientific statement recently concluded that the
verall evidence is consistent with PM2.5 being causally
elated to CV diseases (1). There remains little doubt that
igher ambient PM2.5 levels over a few days can promote
acute CV events (1,2). Although the short-term risks for a
single individual are small, due to the vast number of
individuals affected worldwide, the public health burden of
air pollution is enormous. It has been estimated that up to
4.8% of acute myocardial infarctions are potentially attrib-
utable to recent exposures (2). Although alarming, these
figures (limited to the acute impact of pollution) in actuality
represent an underestimation of the totality of PM2.5-
related CV health effects.
See page 2160
Accumulating evidence supports the reasoning that the
CV risks posed by PM2.5 mirror those of other classical risk
actors (1). The health risks posed by brief perturbations in
ny factor (e.g., an acute elevation in blood pressure) are
arkedly outweighed by those induced by the cumulative
ctions of pervasive long-term abnormalities (e.g., chronic
ypertension). Hence, not only the magnitude but also the
uration of exposure to a risk factor is important when
onsidering the sum totality of ensuing health risks. In the
ontext of air pollution, prospective cohort studies generally
eport an order of magnitude greater increase in CV risk
*Editorials published in the Journal of the American College of Cardiology reflect the
views of the authors and do not necessarily represent the views of JACC or the
American College of Cardiology.
From the †Division of Cardiovascular Medicine, University of Michigan, Ann
Arbor, Michigan; and the ‡Division of Cardiovascular Medicine and Davis Heart
Lung Research Institute, The Ohio State University College of Medicine, Columbus,
Published by Elsevier Inc.u
Ohio. Both authors have reported that they have no relationships relevant to the
contents of this paper to disclose.nduced by several years of PM2.5 exposure compared with
that associated with inhaling similar levels over only a few
days (1,3). One hypothesis put forth to explain these
observations has been that repetitive exposures have cumu-
lative and pernicious effects on the CV system, both
amplifying the adverse effects of other CV risk factors and
increasing the detrimental impact of later PM2.5 exposures
i.e., increasing future susceptibility) (1,4). Emerging data
lso support a role for chronic air pollution exposures in
romoting the genesis of overt disease states, such as
therosclerosis, hypertension, and diabetes mellitus (1,5).
Using data from the MESA (Multi-Ethnic Study of
therosclerosis) cohort, the study by Krishnan et al. (6) in
his issue of the Journal provides new insights into the
dverse CV actions of long-term air pollution exposure.
everaging off of the numerous inherent strengths of the
ESA, the authors performed the first assessment of the
hronic effects of long-term PM2.5 exposure on vascular
ndothelial function as assessed by using flow-mediated
ilation (FMD) of the brachial artery. FMD is a marker of
itric oxide–dependent vasodilation and is a validated
etric of overall vascular endothelial health as well as an
ndependent predictor of CV prognosis (7). However, a
imitation of the MESA study design was that nitroglycerin-
ediated vasodilation was not evaluated; hence, the differ-
ntial impact of air pollution on the endothelium versus
mooth muscle function could not be deciphered (6,7).
The principal finding of this current MESA Air report
as that a 3 g/m3 higher annual average PM2.5 exposure
was associated with a significant 0.3% reduction in FMD
(6). This magnitude of vascular dysfunction, although seem-
ingly small, was analogous to the adverse effects of smoking
or 5 years of aging. This finding suggests that individuals
living in regions affected by even modestly higher air
pollution levels are at risk for experiencing a clinically
pertinent chronic impairment in vascular function. This
novel observation should re-awaken us to the fact that even
“invisible” elements, such as chronic exposure to low levels
of air pollution commonly encountered in the United States,
can have significant adverse effects on CV health.
Several strengths of the current study (6) merit highlight-
ing. It is among the largest investigations linking air
pollution exposure with CV imaging endpoints (1). Al-
though not involving the entire MESA cohort, 3,040
patients is an enviable sample size for an FMD-based study.
This size is likely why the authors were able to find
significant adverse vascular effects despite the small inter-
quartile range (3 g/m3) in PM2.5 exposure levels. The
ichness of the acquired covariates and patient-related in-
ormation also allowed for numerous explorations of effect
odification and sensitivity analyses. In this regard, their
ndings support previous suppositions that women might
e more susceptible (1) and provide new insights into other
otential at-risk groups. The quality and standardization of
http://dx.doi.org/10.1016/j.jacc.2012.08.974ltrasound methods, critically important for FMD proto-
p
i
c
a
c
e
a
w
(
d
(
m
a
a
fi
u
i
o
(
o
p
v
c
p
s
r
p
i
e
b
m
p
p
t
a
w
o
t
2168 Brook and Rajagopalan JACC Vol. 60, No. 21, 2012
Air Pollution and Endothelial Dysfunction November 20/27, 2012:2167–9cols, were also previously well established for this study.
Finally, enormous efforts were paid to developing and
validating estimates of “chronic” residence-level PM2.5 ex-
osures using advanced spatiotemporal models. This exper-
mental strength likely reduced the occurrences of signifi-
ant exposure misclassifications capable of obfuscating true
ir pollution–mediated health effects.
How do the current findings of Krishnan et al. (6)
ompare with previous studies? A number of controlled
xperiments and panel studies have evaluated the effects of
ir pollutants on vascular function; however, these studies
ere conducted only after short-term periods of exposure
1). Previous findings have been mixed, with some reports
emonstrating reduced endothelial-dependent vasodilation
with or without concomitant blunted nitroglycerin-
ediated dilation), whereas others have observed acute
rterial vasoconstriction. How does one reconcile this vari-
bility and place it into context given these new study
ndings? Differences in populations, patient susceptibilities,
nderling CV diseases, and risk factors, as well as the known
ntrinsic variability of endothelial function testing as an
utcome (e.g., biological aspects and technical limitations)
7), are undoubtedly contributing explanations. It is more-
ver possible that the air pollutants evaluated across the
ublished studies may also be partially to blame. PM2.5 is
not a homogeneous entity but is composed of numerous
chemical compounds (1). Differing pollution sources, char-
acteristics, and mixtures could in theory elicit discordant
vascular responses. Unfortunately, because only PM2.5 mass
was evaluated in the current MESA Air report (6), the
specific components (e.g., metals, organic carbon) and
pollution sources (e.g., traffic, regional) most responsible for
perturbing vascular function continue to be obscure. In this
regard, it is interesting to note that the reported FMD
responses differed somewhat among the 5 cities. Perhaps
future analyses of this cohort will provide much-needed
insights into the responsible or most harmful airborne
compounds as well as the impact of multiple co-pollutants
together (e.g., ozone, nitrogen oxides).
The most novel aspect of the current study (6) was the
exploration of the effects of “long-term” PM2.5 exposure on
ascular function. However, deciphering the temporal asso-
iations between exposures and health outcomes is a com-
licated issue that cannot be completely elucidated by any
ingle experiment. It is important to note that the current
esults cannot rule out the possibility that only “subacute”
eriods of PM2.5 exposure (e.g., a few weeks) are all that is
biologically required to cause most (or all) of the PM2.5-
nduced vascular dysfunction attributed to their year-long
xposure metric (4). There is a large missing time window
etween 3 days and 1 year (the acute versus chronic exposure
etrics in their study [6]). This possibility is supported by a
revious publication from MESA (8). Although blood
ressure was not found to be associated with PM2.5 levels
during the previous 1 to 7 days, it was significantly elevated
in relation to the levels during the previous 30 to 60 days. Asignificant relation would have been missed if the health
effect was evaluated solely in regard to the preceding few
days’ concentrations. In the current MESA Air report,
although trends toward reductions in brachial artery diam-
eter and FMD were indeed seen in relation to short-term
PM2.5 exposure levels, some degree of exposure misclassifi-
cations may have obscured the investigators’ ability to
observe significant acute impairments in vascular function.
Their estimations of short-term PM2.5 levels were acknowl-
edged to be inferior to those used for the annual values. Less
sophisticated models coupled with greater variations in
subject time-activity, indoor particle penetration, and the
dominant pollutant sources over the short-term may be
contributing factors. Based on these considerations, the
current findings should not be interpreted as a refutation of
previous publications showing that PM2.5 can be capable of
impairing vascular function within days (1). Rather, the
results are illustrative of the concept that cumulative expo-
sures (of a yet to be precisely determined duration) likely
have more discernible and/or harmful effects on the CV
system.
What are the broader implications of the findings by
Krishnan et al. (6)? The fact that year-long PM2.5 exposures
were related to a decrease in FMD provides an important
mechanistic foundation that supports the plausibility of
prior studies linking air pollutants with the presence and/or
progression of atherosclerosis (1). Their findings also sup-
port the growing number of studies associating PM2.5 with
other facets of the cardiometabolic syndrome (e.g., diabetes
and hypertension) that are also biologically linked to under-
lying endothelial dysfunction (1,5). Considering that endo-
thelial dysfunction is an independent predictor for future
events (7), these findings corroborate the contention that air
pollution is as an insidious and omnipresent CV risk factor
(1). Moreover, the harmful vascular effects induced by
PM2.5 occurred among cities in the United States with
comparatively low air pollution concentrations that were
near or within existing annual National Ambient Air
Quality Standards (1) (15 g/m3). When one considers
he fact that PM2.5 levels often average 5- to 10-fold higher
cross numerous regions populated by billions of people
orldwide (9), the grave global public health consequences
f air pollution corroborated by the findings of this impor-
ant study deserve serious and immediate attention.
Reprint requests and correspondence: Dr. Sanjay Rajagopalan,
OSU Heart Center and Davis Heart Lung Research Institute, 460
West 12th Avenue, 3rd Floor, Room 394, Columbus, Ohio 43210.
E-mail: sanjay.rajagopalan@osumc.edu.
REFERENCES
1. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air
pollution and cardiovascular disease. An update to the scientific state-
ment from the American Heart Association. Circulation 2010;121:
2331–78.
2169JACC Vol. 60, No. 21, 2012 Brook and Rajagopalan
November 20/27, 2012:2167–9 Air Pollution and Endothelial Dysfunction2. Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B. Public health
importance of triggers of myocardial infarction: a comparative risk
assessment. Lancet 2011;377:732–40.
3. Chen H, Goldberg MS, Villeneuve PJ. A systematic review of the
relation between long-term exposure to ambient air pollution and
chronic diseases. Rev Environ Health 2008;23:243–97.
4. Brook RD. Potential health risks of air pollution beyond triggering
acute cardiopulmonary events. JAMA 2008;299:194–6.
5. Brook RD, Rajagopalan S. Particulate matter, air pollution, and blood
pressure. J Am Soc Hypertens 2009;3:332–50.
6. Krishnan RM, Adar SD, Szpiro AA, et al. Vascular responses to long-
and short-term exposure to fine particulate matter: MESA Air (Multi-
Ethnic Study of Atherosclerosis and Air Pollution. J Am Coll Cardiol
2012;60:2158–66. d7. Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of
endothelial function. From research into clinical practice. Circulation
2012;126:753–67.
8. Auchincloss AH, Diez Roux AV, Dvonch JT, et al. Associations
between recent exposure to ambient fine particulate matter and blood
pressure in the Multi-Ethnic Study of Atherosclerosis (MESA). Envi-
ron Health Perspect 2008;116:486–91.
9. Van Donkelaar, Martine RV, Brauer M, et al. Global estimates of
ambient fine particulate matter concentrations from satellite-based
aerosol optical depth: development and application. Environ Health
Perspect 2010;118:847–55.Key Words: air pollution y endothelial dysfunction y flow-mediated
ilation y multiethnic cohort.
